In the all-too-common debate over building lab facilities versus outsourcing, the best strategy may be the middle ground: licensing.
Ravi Samavedam
Advertisement
Ravi Samavedam is chief innovation officer at Azzur Group.
Articles by Ravi Samavedam
Advertisement
Latest Updated Articles
Threading the Needle Between DIY and CDMOPublished: November 15th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Report - Digital Transformation in Biopharma: The Gap Between Hype and Implementation
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Big Biopharma Investment in CGTs Will Redefine the Industry Pipeline
4
Reducing CAR-T Manufacturing Times and Cost: Q&A with Trenchant’s Jon Ellis
5
